Eqis Capital Management Inc. bought a new stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 8,533 shares of the company’s stock, valued at approximately $296,000.
A number of other large investors have also recently bought and sold shares of the stock. BBVA USA Bancshares Inc. purchased a new stake in Prestige Consumer Healthcare during the third quarter valued at approximately $326,000. Massachusetts Financial Services Co. MA lifted its position in Prestige Consumer Healthcare by 28.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 792,320 shares of the company’s stock valued at $27,486,000 after acquiring an additional 174,117 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in Prestige Consumer Healthcare by 100.6% during the third quarter. Tower Research Capital LLC TRC now owns 1,657 shares of the company’s stock valued at $57,000 after acquiring an additional 831 shares during the last quarter. Tibra Equities Europe Ltd purchased a new stake in Prestige Consumer Healthcare during the third quarter valued at approximately $465,000. Finally, Russell Investments Group Ltd. increased its stake in Prestige Consumer Healthcare by 15.7% during the 3rd quarter. Russell Investments Group Ltd. now owns 396,109 shares of the company’s stock valued at $13,676,000 after purchasing an additional 53,620 shares in the last quarter.
PBH has been the topic of a number of recent analyst reports. ValuEngine upgraded shares of Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a research note on Friday, July 26th. DA Davidson upped their price target on shares of Prestige Consumer Healthcare from $31.00 to $32.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. CIBC cut their price target on shares of Prestige Consumer Healthcare from $94.00 to $81.00 in a research note on Tuesday, November 12th. TheStreet upgraded shares of Prestige Consumer Healthcare from a “d+” rating to a “c-” rating in a research note on Tuesday, July 23rd. Finally, TD Securities cut their price target on shares of Prestige Consumer Healthcare from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Tuesday, November 12th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and one has issued a buy rating to the company. Prestige Consumer Healthcare presently has an average rating of “Hold” and a consensus target price of $64.06.
Shares of Prestige Consumer Healthcare stock opened at $37.64 on Friday. The company has a current ratio of 2.08, a quick ratio of 1.22 and a debt-to-equity ratio of 1.60. Prestige Consumer Healthcare Inc has a 12-month low of $26.25 and a 12-month high of $39.43. The firm has a market capitalization of $1.92 billion, a price-to-earnings ratio of 13.54, a PEG ratio of 2.09 and a beta of 0.87. The firm’s 50 day simple moving average is $35.77 and its two-hundred day simple moving average is $32.73.
Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, October 31st. The company reported $0.68 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.02. The business had revenue of $238.07 million for the quarter, compared to analyst estimates of $237.17 million. Prestige Consumer Healthcare had a negative net margin of 3.56% and a positive return on equity of 12.68%. Prestige Consumer Healthcare’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.65 EPS. On average, sell-side analysts predict that Prestige Consumer Healthcare Inc will post 2.82 EPS for the current fiscal year.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Featured Story: Key terms to understand channel trading
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.